Macrocyclics produces cGMP peptide in support of NET clinical trial
November 1, 2016
Macrocyclics was contracted by Radiomedix and AREVA Med to produce the cGMP peptide conjugate that…
News
Macrocyclics Inaugurates New Production Facility
April 13, 2016
AREVA Med has launched operations at its second high-purity lead-212 (²¹²Pb) production facility…
New Plano Facility on Schedule to Open in 2nd Quarter of 2016
January 21, 2016
AREVA Med’s second high-purity lead-212 (²¹²Pb) production facility is now well advanced in…
Press Releases
Read AllAREVA Med’s Second Production Facility on Schedule to Open in 2nd Quarter of 2016
January 21, 2016 - Plano, Texas
AREVA Med & RadioMedix partner to develop new treatment against Neuroendocrine Tumors with Lead-212
May 18, 2015 - Houston, Texas & Bethesda, Maryland
Events
22Jun
SNMMI – Society of Nuclear Medicine and Molecular Imaging 2019
Anaheim, CA
Please visit the Macrocyclics team at Booth #843 between June 22 & 25…
23Jun
SNMMI – Society of Nuclear Medicine and Molecular Imaging 2018
Philadelphia, PA
Please visit the Macrocyclics team at Booth #310 between June 23 & 26…
21Oct
EANM – European Association of Nuclear Medicine – 2017
Vienna, Austria
Please visit the Macrocyclics team at Booth #234 in Hall X2 between October 20 & 25…
30May
10th International Symposium on Targeted Alpha Therapy, TAT-10
Kanazawa, Japan
Meet us at the 10th International Symposium on Targeted Alpha Therapy.